Works matching IS 02704137 AND DT 2022 AND VI 82 AND IP 16
Results: 10
CD47 (don't eat me signal) expression levels and its relationship with clinicopathologic features in early‐stage prostate carcinoma.
- Published in:
- Prostate, 2022, v. 82, n. 16, p. 1564, doi. 10.1002/pros.24432
- By:
- Publication type:
- Article
Are higher pre‐diagnosis follicle stimulating hormone levels associated with long‐term prostate cancer risk?
- Published in:
- Prostate, 2022, v. 82, n. 16, p. 1558, doi. 10.1002/pros.24429
- By:
- Publication type:
- Article
Prostate cancer cells demonstrate unique metabolism and substrate adaptability acutely after androgen deprivation therapy.
- Published in:
- Prostate, 2022, v. 82, n. 16, p. 1547, doi. 10.1002/pros.24428
- By:
- Publication type:
- Article
Circulating microRNA profiling for prediction of oncological outcomes in prostate cancer patients following radical prostatectomy.
- Published in:
- Prostate, 2022, v. 82, n. 16, p. 1537, doi. 10.1002/pros.24427
- By:
- Publication type:
- Article
PSA provocation by bipolar androgen therapy may predict duration of response to first‐line androgen deprivation: Updated results from the BATMAN study.
- Published in:
- Prostate, 2022, v. 82, n. 16, p. 1529, doi. 10.1002/pros.24426
- By:
- Publication type:
- Article
Prostate cancer grade downgrading at time of prostatectomy provides risk‐stratification insight into future tumor behavior after prostatectomy.
- Published in:
- Prostate, 2022, v. 82, n. 16, p. 1520, doi. 10.1002/pros.24425
- By:
- Publication type:
- Article
Localization of macrophage subtypes and neutrophils in the prostate tumor microenvironment and their association with prostate cancer racial disparities.
- Published in:
- Prostate, 2022, v. 82, n. 16, p. 1505, doi. 10.1002/pros.24424
- By:
- Publication type:
- Article
Differential effects of omega‐3 PUFAS on tumor progression at early and advanced stages in TRAMP mice.
- Published in:
- Prostate, 2022, v. 82, n. 16, p. 1491, doi. 10.1002/pros.24421
- By:
- Publication type:
- Article
Radiographic paradoxical response in metastatic castrate‐resistant prostate cancer (mCRPC) managed with new generation anti‐androgens: a retrospective analysis.
- Published in:
- Prostate, 2022, v. 82, n. 16, p. 1483, doi. 10.1002/pros.24413
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Prostate, 2022, v. 82, n. 16, p. 1481, doi. 10.1002/pros.24166
- Publication type:
- Article